NCT07522736 Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
| NCT ID | NCT07522736 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Intrathecal Dexmedetomidine |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-03-01 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * American Society of Anesthesiologists (ASA) physical status I-II. * Male patients scheduled for knee orthopedic surgery. Exclusion Criteria: * Patients with psychiatric disorders. * History of drug addiction. * Contraindication for regional anesthesia. * History of hypersensitivity to the study drugs. * Previous administration of opioids and/or other central nervous system depressants during current hospital admission.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07522736 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Intrathecal Dexmedetomidine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07522736 currently recruiting?
Yes, NCT07522736 is actively recruiting participants. Contact the research team at ahmed.ali39348@postgrad.kasralainy.edu.eg for enrollment information.
Where is the NCT07522736 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07522736 clinical trial?
NCT07522736 is sponsored by Cairo University. The trial plans to enroll 120 participants.